Magnical D
Natural health product licensed in Canada
- Licence holder
- Partner.Co Canada
- NPN or DIN-HM
- 80133945
- Status
- Active licence
- Licence date
- 29 August 2024
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine K2 Source : Ménaquinone 7 | 7.5 mcg | 15 µg |
| Magnésium Source : Magnesium amino acid chelate | 100 mg | 200,000 µg |
| Malpighia glabra Source : Malpighia glabra - fruit Extract : Matériel brut frais Extraction ratio : 2:1 Dry plant equivalent : 12.5 mg Potency : 25 % Vitamin C | 6.25 mg | Not calculated |
| Grifola frondosa Source : Grifola frondosa - Fruiting body Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 25 mg Potency : 30 % Polysaccharides | 6.25 mg | Not calculated |
Non-medicinal ingredients
Sel de mer, Cellulose microcristalline, Poudre de racine de Zingiber Officinale (Gingembre), Lécithine, Hypromellose, Silice, Riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of fungal polysaccharides with immunomodulating properties. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Helps in bone development. Helps in energy metabolism/(and) tissue formation. Helps in the absorption (and use) of calcium and phosphorus. Helps in the development and maintenance of bones/(and) teeth. Helps in the maintenance of bones. Helps maintain/support bone health. Helps to build strong bones/(and) teeth. Helps to maintain/support heart muscle function. Helps to maintain/support immune function/the immune system. Helps to maintain/support normal electrolyte balance. Helps to maintain/support normal muscle function, including the heart muscle. Helps to maintain/support normal muscle function. Helps to maintain/support the body's ability to metabolize nutrients. Helps with immune function/the immune system. Source of/Provides (an) electrolyte(s) for the maintenance of good health. Source of/Provides (an) electrolyte(s). Vitamin D intake, when combined with sufficient calcium, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of (an) antioxidant(s)/Provides (an) antioxidant(s). Helps in the development and maintenance of bones/(and) teeth in young adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80133945
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.